15-year remission in refractory FLT3-mutated AML attained by sorafenib

Ann Hematol. 2024 Nov;103(11):4801-4803. doi: 10.1007/s00277-024-06012-3. Epub 2024 Sep 25.

¹ Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
² Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany. [email protected].

No abstract available

Keywords: Acute myeloid leukemia; Donor lymphocyte infusion; FLT3-ITD; Sorafenib; WT1.